Kilitch Drugs (India) Limited
KILITCH.BO
Price:
$343.15
Market Cap:
$5.86B
Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India. The company offers parenteral and nasal products, including gastroenterology, anti-inflammatory, anticonvulsant/antiepileptic, anti-malarial, aminoglycoside, antibacterial, anti-hypertensive, anti-infective, diagnostic, sympathomimetic, local anesthetic, neurotonic, uterine stimulant, external preparation, non-steroidal anti-inflammatory, oncology, ophthalmic, and other drugs, as well as vaccines and veterinary products in the form of liquid ampoules, vials, and dry powder injectables. Its parenteral and nasal products also include iron supplements for the treatment of anemia; and mete...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2002-03-05
Stock Exchange
BSE
Ticker
KILITCH.BO
The ROE as of December 2025 (TTM) for Kilitch Drugs (India) Limited (KILITCH.BO) is 14.35%
According to Kilitch Drugs (India) Limited’s latest financial reports and current stock price. The company's current ROE is 14.35%. This represents a change of 299.62% compared to the average of 3.59% of the last 4 quarters.
Kilitch Drugs (India) Limited (KILITCH.BO) Historical ROE (quarterly & annually)
How has KILITCH.BO ROE performed in the past?
The mean historical ROE of Kilitch Drugs (India) Limited over the last ten years is 2.59%. The current 14.35% ROE has changed 452.98% with respect to the historical average. Over the past ten years (40 quarters), KILITCH.BO's ROE was at its highest in in the March 2025 quarter at 5.14%. The ROE was at its lowest in in the March 2015 quarter at -1.14%.
Average
2.59%
Median
3.88%
Minimum
-10.30%
Maximum
13.20%
Kilitch Drugs (India) Limited (KILITCH.BO) ROE by Quarter and Year
Discovering the peaks and valleys of Kilitch Drugs (India) Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.17%
Maximum Annual ROE = 13.20%
Minimum Annual Increase = -152.36%
Minimum Annual ROE = -10.30%
| Year | ROE | Change |
|---|---|---|
| 2025 | 13.20% | 59.33% |
| 2024 | 8.28% | 20.18% |
| 2023 | 6.89% | 30.12% |
| 2022 | 5.30% | 83.43% |
| 2021 | 2.89% | 305.56% |
| 2020 | 0.71% | -77.49% |
| 2019 | 3.16% | -31.21% |
| 2018 | 4.60% | -152.36% |
| 2017 | -8.78% | -14.69% |
| 2016 | -10.30% | 4.17% |
Kilitch Drugs (India) Limited (KILITCH.BO) Average ROE
How has KILITCH.BO ROE performed in the past?
The current ROE of Kilitch Drugs (India) Limited (KILITCH.BO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.46%
5-year avg
7.31%
10-year avg
2.59%
Kilitch Drugs (India) Limited (KILITCH.BO) ROE vs. Peers
How is KILITCH.BO’s ROE compared to its peers?
Kilitch Drugs (India) Limited’s ROE is less than Venus Remedies Limited (10.18%), less than Venus Remedies Limited (10.18%), less than Ind-Swift Laboratories Limited (23.65%), less than Ind-Swift Laboratories Limited (23.65%), less than Medicamen Biotech Limited (4.17%), less than Medicamen Biotech Limited (4.17%), less than Shree Ganesh Remedies Limited (14.15%), less than Prevest Denpro Limited (18.75%), less than Albert David Limited (1.56%), less than Jenburkt Pharmaceuticals Limited (19.29%),
| Company | ROE | Market cap |
|---|---|---|
| 10.18% | $10.15B | |
| 10.18% | $10.03B | |
| 23.65% | $7.07B | |
| 23.65% | $6.99B | |
| 4.17% | $5.11B | |
| 4.17% | $5.26B | |
| 14.15% | $5.71B | |
| 18.75% | $5.26B | |
| 1.56% | $4.48B | |
| 19.29% | $4.85B |
Build a custom stock screener for Kilitch Drugs (India) Limited (KILITCH.BO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kilitch Drugs (India) Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Kilitch Drugs (India) Limited (KILITCH.BO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Kilitch Drugs (India) Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Kilitch Drugs (India) Limited's ROE?
How is the ROE calculated for Kilitch Drugs (India) Limited (KILITCH.BO)?
What is the highest ROE for Kilitch Drugs (India) Limited (KILITCH.BO)?
What is the 3-year average ROE for Kilitch Drugs (India) Limited (KILITCH.BO)?
What is the 5-year average ROE for Kilitch Drugs (India) Limited (KILITCH.BO)?
How does the current ROE for Kilitch Drugs (India) Limited (KILITCH.BO) compare to its historical average?